Assignee
EDGEWISE THERAPEUTICS INC
US·10 granted patents·14 pending applications·29 citations·filing 2020–2025
Top patents by PatentIndex Score
24 records- 0195US11091464B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Aug 17, 2021·11 cites·30 claims
- 0294US11236065B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Feb 1, 2022·7 cites·30 claims
- 0393US12012395B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2021·Granted Jun 18, 2024·3 cites·39 claims
- 0493US11390606B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2020·Granted Jul 19, 2022·5 cites·25 claims
- 0591US12240833B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2022·Granted Mar 4, 2025·2 cites·28 claims
- 0690US12240831B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2023·Granted Mar 4, 2025·1 cites·51 claims
- 0781US2025223278A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0876US2025340526A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 0972US12448369B2Quinolinone amide compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Oct 21, 2025·0 cites·56 claims
- 1072US2026008774A1Quinolinone amide compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1170US12509431B21,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Dec 30, 2025·0 cites·30 claims
- 1268US12415794B2Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2021·Granted Sep 16, 2025·0 cites·29 claims
- 1365US2022362242A1Methods and compositions for treating movement disordersEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1464US2024336609A1Pyridazinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1563US12559464B2Quinazolinone dione compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2024·Granted Feb 24, 2026·0 cites·30 claims
- 1661US2023338375A1Substituted pyridazinones for use in the treatment of neuromuscular diseasesEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1761US2023321091A1Substituted pyridazinones for use in the treatment of neuromuscular diseasesEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1861US2023293518A1Substituted pyridazinones for use in the treatment of neuromuscular diseasesEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1960US2025361213A11,4-dihydroquinazolinone compounds and uses thereofEDGEWISE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2060US2023150977A1Pyridazinone compounds for the treatment of neuromuscular diseasesEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2160US2023159513A1Pyridazinone compounds for the treatment of neuromuscular diseasesEDGEWISE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2259US2025388564A1Methods of manufacturing pyridazinone compoundsEDGEWISE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2357US2021060012A1Methods and compositions for treating movement disordersEDGEWISE THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 2455US2025387392A1Pyridazinone compositions for the treatment of neuromuscular conditionsEDGEWISE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when EDGEWISE THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →